In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

Henry Schein receives $250 million strategic investment from KKR, making them largest non-index fund shareholder.

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million investment.

Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...

MELVILLE, N.Y. - Global investment firm KKR is set to become a significant shareholder in Henry Schein (NASDAQ:HSIC), Inc., the world's largest provider of health care solutions to office-based dental ...